A red meat-derived glycan promotes inflammation and cancer progression.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model and biochemical assay
PubMed 25548184 · doi:10.1073/pnas.1417508112
What was done
Researchers quantified free and bound nonhuman sialic acid (Neu5Gc) in common food items using an improved survey method. They then evaluated the biological impact of dietary Neu5Gc in human-like Neu5Gc-deficient mice by feeding them bioavailable Neu5Gc and challenging or immunizing them with anti-Neu5Gc antibodies to measure systemic inflammation and tumor formation.
What was found
Neu5Gc was selectively enriched in mammalian red meat in a bioavailable, bound form capable of metabolic incorporation into tissues. In Neu5Gc-deficient mice, dietary Neu5Gc combined with anti-Neu5Gc antibody challenge provoked systemic inflammation. Furthermore, mice immunized against Neu5Gc and fed bioavailable Neu5Gc exhibited accumulation of Neu5Gc and a significantly higher incidence of hepatocellular carcinomas. The abstract provides no exact numerical values, statistical metrics, or cohort sizes.
Why it matters
This work identifies an immune-mediated mechanism linking dietary mammalian glycan incorporation to chronic inflammation and carcinoma progression, offering a biological framework for epidemiological observations.
Limits
The study was conducted in a mouse model and food assays without direct human clinical outcome measurements. The primary malignancy observed was hepatocellular carcinoma rather than colorectal carcinoma, which is the cancer most prominently linked to red meat in human epidemiology. Animal cohort sizes, exact dosages, and tumor incidence numbers were not reported in the abstract.
Cited by
- supports Red meat contains the sialic acid Neu5Gc, which triggers an inflammatory response in all humans due to CMAH gene inactivation.